Health
UK starts mass COVID vaccination programme today
Britain on Tuesday recorded a turning point in the fight against the coronavirus pandemic, as it began the biggest vaccination programme in the country’s history with a new COVID-19 jab.
The first patients in line on what has been dubbed “V-Day” — the over-80s, care home workers and at-risk frontline health and social care staff — will roll up their sleeves for an initial dose from early morning.
They will then require a second jab in 21 days’ time.
Last week Britain became the first country to approve the Pfizer-BioNTech vaccine, raising hopes of a breakthrough in the pandemic, which has killed more than 1.5 million worldwide.
Britain has been one of the worst-affected countries in the world, with more than 61,000 deaths in the outbreak from 1.6 million cases.
Prime Minister Boris Johnson, who spent days in intensive care with Covid-19 earlier this year, called it a “huge step forward in the UK’s fight against coronavirus”.
UK Health Secretary Matt Hancock, who has offered to have the jab on live television to allay public fears, said the roll-out was a “key moment” that would protect the most vulnerable.
The head of the state-run National Health Service in England, Simon Stevens, said it was a “decisive turning point” against the “greatest health challenge” since the NHS was founded in 1948.
Regulatory approval for the vaccine was given last Wednesday, sparking a race against time to prepare scores of vaccination centres across the country.
The UK has ordered 40 million doses of the jab — enough to vaccinate 20 million people — with 800,000 in the first batch.
Up to four million doses are expected by the end of December.
Queen could lead way
The mass vaccination drive is a coordinated response by all four nations of the UK — England, Scotland, Wales and Northern Ireland — which normally set their own health policies.
The public has been largely favourable to the rapid approval of the vaccine, but ministers and health professionals are aware they still need to combat mistrust.
The independent Medicines and Healthcare products Regulatory Agency maintains that no corners were cut and its assessment and approval procedures met stringent international norms.
NHS England said thousands had already been given the jab during trials with no serious side effects.
Nevertheless, it has been reported Queen Elizabeth II, who at 94 is among those first in the line for the vaccination because of her age, could front a public awareness campaign urging compliance.
The government said it will hand out vaccine cards to remind people to get the booster after three weeks, but insisted it was not introducing immunity certificates.
The chief medical officers of England, Scotland, Wales and Northern Ireland said the vaccine will as a result only have a “marginal impact” on hospital numbers over the winter months.
Johnson called for patience and urged the public to stick to strict social distancing guidelines to prevent a spike in cases, particular as rules are relaxed over Christmas.
Health officials have already run into a logistical headache about how to administer the vaccine to elderly or infirm care home residents.
The vaccine needs to be stored at -70 degrees Celsius (-94 Fahrenheit), leaving hospitals and other medical hubs as the only places able to deal with such ultra-low temperatures.
With the Pfizer-BioNTech drug made in Belgium, concerns have also been raised about potential disruption to supply when Britain leaves the European Union’s single market and customs union.
But the UK government said the military is on stand-by to air-lift the vaccine if there is any border disruption from January 1.
The bulk of Britain’s vaccine requirements are expected to be met by a jab developed by AstraZeneca and the University of Oxford, which is awaiting regulatory approval.
The government has ordered an initial 100 million doses of the drug, which is cheaper to manufacture, and easier to store and transport using conventional fridges.
-AFP
![]()
Health
No Evidence Of Hantavirus In Nigeria — NCDC
No Evidence Of Hantavirus In Nigeria — NCDC
The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed that there is currently no evidence of hantavirus cases in Nigeria, while reassuring Nigerians that the country remains on heightened surveillance for emerging infectious diseases. The agency said it continues to monitor global health developments and strengthen its systems to quickly detect and respond to any unusual disease patterns.
The NCDC explained that hantaviruses are a group of viruses mainly carried by rodents such as rats and mice. Humans can become infected through direct contact with infected rodents or by exposure to contaminated urine, droppings, saliva, or dust particles from rodent-infested environments.
The agency noted that hantavirus infection, although rare, can lead to serious illness in some cases. It listed symptoms as including fever, fatigue, body aches, headache, and gastrointestinal issues, while severe cases may progress to difficulty breathing and other respiratory complications.
READ ALSO:
- Troops Neutralise Over 50 ISWAP Fighters In Failed Night Attack On Yobe Military Base
- Dangote Refinery Opens 2026 Graduate Trainee Programme For Young Professionals
- 2027: Support Tinubu For Stability, Omokri, FFK Tell Nigerians
Health officials also clarified that while some strains of the virus, such as the Andes virus, have been linked to limited human-to-human transmission in rare circumstances, there is no evidence of any such transmission or outbreak in Nigeria.
In a public health advisory, the NCDC stated that the overall risk to the general public remains low but advised Nigerians to maintain proper hygiene and environmental sanitation to reduce exposure to rodents and other disease carriers.
The agency recommended that households and communities keep surroundings clean to prevent rodent infestation, store food securely in sealed containers, dispose of waste properly, avoid contact with rodents and their droppings, and use protective equipment when cleaning contaminated areas. It also encouraged regular handwashing and strict infection prevention practices in both communities and healthcare facilities.
The NCDC further assured Nigerians that the country’s disease surveillance system remains active and capable of detecting and responding to outbreaks. It said lessons from previous public health emergencies, including Lassa fever, COVID-19, cholera, and mpox, have strengthened Nigeria’s preparedness and response capacity.
Officials urged the public not to panic, stressing that there is currently no confirmed case of hantavirus infection in the country. They also warned against misinformation, advising Nigerians to rely only on verified updates from official health sources.
As of the time of filing this report, the NCDC maintains that Nigeria remains free of hantavirus cases while continuing routine monitoring of global and local health threats.
No Evidence Of Hantavirus In Nigeria — NCDC
![]()
Health
Breakthrough Study Shows Nasal Spray Could Slow Brain Ageing
Breakthrough Study Shows Nasal Spray Could Slow Brain Ageing
Researchers have developed an experimental nasal spray treatment that may help reduce brain inflammation and improve memory, raising new possibilities for tackling age-related cognitive decline and neurodegenerative conditions. The study was carried out at the Texas A&M University College of Medicine, where scientists examined whether targeted delivery of biological compounds through the nose could influence brain function and slow aspects of brain ageing. Researchers say the findings suggest that certain effects of ageing on the brain may be more modifiable than previously understood, particularly when inflammation in memory-related regions is addressed.
As people age, the brain can experience a gradual build-up of low-level inflammation in areas responsible for memory and learning. This process, known as “neuroinflammaging,” has been associated with slower thinking, reduced memory performance, and a higher risk of conditions such as Alzheimer’s disease and dementia. The research team noted that targeting this inflammation could be key to preserving cognitive function in older adults.
The study was led by Professor Ashok Shetty, alongside researchers Madhu Leelavathi Narayana and Maheedhar Kodali. The team used tiny biological particles known as extracellular vesicles as the basis for the treatment. These vesicles carry microRNAs, which help regulate gene activity in cells. When delivered via a nasal spray, they are able to travel directly to the brain, bypassing the blood-brain barrier, which typically limits the effectiveness of many treatments.
READ ALSO:
- Osun Rewards 31 Top WAEC Students With Scholarships, Cash
- Meningitis Outbreak in Sokoto State Kills 34, Infects 254 Across Nine LGAs
- 2027 Rivers Guber: Wike Says No Endorsement Yet, Denies Working With Fubara
Once in the brain, the treatment was found to reduce inflammation and improve the function of mitochondria, the structures responsible for producing energy in brain cells. This improvement is believed to support better cognitive performance. In experimental models, subjects that received the nasal spray showed improvements in memory-related tasks, including better recognition of familiar objects and improved responses to environmental changes.
Researchers observed that some of these improvements appeared within weeks of treatment and, in certain cases, lasted for several months, suggesting a potentially sustained impact on brain function. The findings were published in the Journal of Extracellular Vesicles, a peer-reviewed scientific journal focused on cellular communication and regenerative medicine.
Scientists believe the results could eventually contribute to new treatments for dementia, Alzheimer’s disease, and other age-related neurological disorders, as well as recovery therapies for stroke patients. However, the researchers stressed that the work is still in its early stages and has so far only been tested in experimental models.
Experts involved in the study cautioned that human clinical trials are necessary before any conclusions can be drawn about safety, effectiveness, or long-term use. They also noted that while early results are promising, many treatments that succeed in laboratory studies do not always produce the same outcomes in humans.
Despite these limitations, the study represents an important step in understanding how brain inflammation, cellular energy loss, and ageing are connected. Researchers say the goal is not only to treat disease but also to support healthier brain ageing, helping people maintain memory, focus, and mental performance later in life.
Breakthrough Study Shows Nasal Spray Could Slow Brain Ageing
![]()
Health
Meningitis Outbreak in Sokoto State Kills 34, Infects 254 Across Nine LGAs
Meningitis Outbreak in Sokoto State Kills 34, Infects 254 Across Nine LGAs
A meningitis outbreak in Sokoto State has claimed at least 34 lives and infected 254 persons across nine Local Government Areas (LGAs), prompting urgent public health interventions by the state government. The State Commissioner for Health, Faruk Abubakar-Wurno, disclosed this on Wednesday while briefing journalists on the severity and spread of the outbreak, describing it as a serious public health emergency in Sokoto State.
To contain the spread, the Sokoto State Government has established isolation and treatment centres in Dogondaji and Kurawa communities, located in Tambuwal and Sabon Birni LGAs. Health authorities confirmed that 201 patients treated in government health facilities have been discharged, indicating some progress in managing the outbreak and stabilising infected patients.
READ ALSO:
- 2027 Rivers Guber: Wike Says No Endorsement Yet, Denies Working With Fubara
- Tinubu Approves ₦250bn for Student Hostel Construction Nationwide – Alausa
- Man Confesses: I Got N500,000 to Bath Spa Worker with Acid
The commissioner provided a breakdown of confirmed cases across the nine affected LGAs: Sabon Birni recorded 63 cases, Wamakko 60, Shagari 51, Tambuwal 34, Dange-Shuni 26, Kebbe 16, Bodinga 2, Kware 2, and Gada 1. He added that laboratory tests confirmed eight positive cases of meningitis, raising concerns about ongoing community transmission.
Health officials noted that children between the ages of one and 15 years are the most affected group in the outbreak. They also identified overcrowding, dry weather conditions, and extreme heat as key factors driving the spread of meningitis infection in Sokoto communities, especially during the current seasonal conditions.
The Sokoto State Government has intensified disease surveillance, contact tracing, and public awareness campaigns across affected LGAs to curb further spread. Residents have been urged to adopt preventive measures such as sleeping in well-ventilated spaces and maintaining proper hygiene, particularly during periods of extreme heat that increase vulnerability to infection.
The commissioner further disclosed that surveillance officers have been deployed across affected areas, while laboratory capacity and access to essential medications have been strengthened to ensure faster diagnosis and treatment. Authorities say these coordinated efforts are aimed at containing the meningitis outbreak in Sokoto State and preventing further loss of lives as monitoring continues.
Meningitis Outbreak in Sokoto State Kills 34, Infects 254 Across Nine LGAs
![]()
-
metro2 days agoVIDEO: Sisi Alagbo Secures Endorsement Deal After Viral Threesome Video Controversy
-
metro20 hours ago16 Killed In Fatal Lokoja–Okene Highway Crash
-
metro2 days agoISWAP Overrun Army Base in Borno, Several Soldiers Killed, Lieutenant Colonel Injured
-
metro2 days agoPolice Arrest Two Suspects Over Gun Linked to Killing of Oghenemine Ogidi in Delta
-
International3 days agoFrench Vessel Attacked in Strait of Hormuz, Crew Injured
-
International3 days agoCNN Founder Ted Turner Dies at 87
-
News3 days agoSenate Erupts as Akpabio, Oshiomhole Clash Over Controversial Rule Amendments
-
metro1 day agoGrand Chief Imam of Oyo Land Visits CAN Leadership, Advocates Religious Harmony
You must be logged in to post a comment Login